Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04699591 · ClinicalTrials.gov registry record · NA
Compassionate Use of Domperidone for Refractory Gastroparesis
A NA study of Gastroparesis and Gastroesophageal Reflux, sponsored by Children's Mercy Hospital Kansas City.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04699591 is a NA study of Gastroparesis and Gastroesophageal Reflux that is actively recruiting participants, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 20 participants, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04699591, a NA study of Gastroparesis and Gastroesophageal Reflux, is actively recruiting participants, sponsored by Children's Mercy Hospital Kansas City.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this program is to allow the use of domperidone in children from 12 to 21 years of age with symptoms related to motility disorders and Gastroesophageal reflux disease (GERD) who have failed all the standard treatments for their condition.
Conditions Studied
Interventions
- DRUG Domperidone
Study Locations (1)
Missouri
- Children's Mercy Hospitals and Clinics - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-04 |
| Est. Completion | 2035-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04699591
The ClinicalTrials.gov registry entry for NCT04699591 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (93% lower). The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Gastroparesis appearing as the primary indexed condition, and to 1 intervention - of which Domperidone is the first listed.
NCT04699591 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT04699591 about?
NCT04699591 is a clinical study titled "Compassionate Use of Domperidone for Refractory Gastroparesis". The purpose of this program is to allow the use of domperidone in children from 12 to 21 years of age with symptoms related to motility disorders and Gastroesophageal reflux disease (GERD) who have failed all the standard treatments for their condition.
What is the current status of trial NCT04699591?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2013-04. Estimated completion is 2035-12.
What conditions does trial NCT04699591 study?
This clinical trial studies the following conditions: Gastroparesis, Gastroesophageal Reflux, GERD.
What interventions are being tested in trial NCT04699591?
The interventions under investigation include: Domperidone (DRUG).
Who is sponsoring clinical trial NCT04699591?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04699591 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
RECRUITING · NA
-
Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis
RECRUITING · NA
-
Study of Enhanced Programming Stimulation with the Enterra® Therapy System
RECRUITING · NA
-
Study of Enterra Programming with Nocturnal Cycling in Gastroparetics
RECRUITING · NA
-
Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.